Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (apre una nuova finestra)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Fonte‎: Intensive Care Med 2013;39(11):2011-9.

Indicizzato‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (apre una nuova finestra)

Pediatric red blood cell transfusions increase resource use. (apre una nuova finestra)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Fonte‎: J Pediatr 2003;142(2):123-7.

Indicizzato‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (apre una nuova finestra)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (apre una nuova finestra)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Fonte‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indicizzato‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (apre una nuova finestra)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (apre una nuova finestra)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Fonte‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indicizzato‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (apre una nuova finestra)

Economic evaluation of cell salvage in pediatric surgery. (apre una nuova finestra)

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

Fonte‎: Paediatr Anaesth 2013;23(11):1027-34.

Indicizzato‎: PubMed 23952976

DOI‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 (apre una nuova finestra)